FINNENCE ▪ THE WIRE FILE
THE WIRE · № 68985
News■ Unclear/unknown
Gastro Health and House Rx Announce Launch of Medically Integrated Dispensing
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-07 12:00 UTC
LAST UPDATE2026-10-07 12:00 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A dispensing partnership is operational news with no disclosed financial terms or listed ticker.
Operational partnership, minimal market signal
CATALYST TO WATCH
None identifiable from text
MAIN RISK
Private companies, no tradable exposure
FULL DISPATCH
Gastro Health and House Rx are partnering to modernize how Gastro Health's meet the needs of its evolving patient population, reducing patients' time to first dose across its network SAN FRANCISCO, Oct. 7, 2026 /PRNewswire/ -- House Rx, the leader in medically integrated dispensing...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Trulieve Repays $65 Million Mortgage Strengthening Balance Sheet2026-10-07 12:00 UTC
Trulieve Repays $65 Million Mortgage Strengthening Balance Sheet2026-10-07 12:00 UTC
→CORRELATIONshares Healthcare
Mentara Therapeutics Launches to Advance MTA-304, a Phase 2-Ready PDE10A Inhibitor, for Levodopa-Induced Dyskinesia in Parkinson's Disease2026-10-07 12:00 UTC
Mentara Therapeutics Launches to Advance MTA-304, a Phase 2-Ready PDE10A Inhibitor, for Levodopa-Induced Dyskinesia in Parkinson's Disease2026-10-07 12:00 UTC
→CORRELATIONshares Healthcare
MimiVax and Roswell Park Announce Results from Phase 2b SURVIVE Trial of SurVaxM in Newly Diagnosed Glioblastoma2026-10-07 12:00 UTC
MimiVax and Roswell Park Announce Results from Phase 2b SURVIVE Trial of SurVaxM in Newly Diagnosed Glioblastoma2026-10-07 12:00 UTC
→CORRELATIONshares Healthcare
Immunic to Present New Clinical, Biomarker and Preclinical Data on Vidofludimus Calcium at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting2026-10-07 12:00 UTC
Immunic to Present New Clinical, Biomarker and Preclinical Data on Vidofludimus Calcium at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting2026-10-07 12:00 UTC
→CORRELATIONshares Healthcare
Lakewood-Amedex Biotherapeutics Announces Positive Preclinical Data in Urinary Tract and Pulmonary Infection Indications with Bisphosphocin® Compounds2026-10-07 12:02 UTC
Lakewood-Amedex Biotherapeutics Announces Positive Preclinical Data in Urinary Tract and Pulmonary Infection Indications with Bisphosphocin® Compounds2026-10-07 12:02 UTC
→CORRELATIONshares Healthcare
Where to Invest $100,000: Healthcare, AI and High-Quality Bonds2026-10-07 11:00 UTC
Where to Invest $100,000: Healthcare, AI and High-Quality Bonds2026-10-07 11:00 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.